Seguir
rolf Kiessling
rolf Kiessling
Afiliación desconocida
Dirección de correo verificada de ki.se
Título
Citado por
Citado por
Año
Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
K Kärre, HG Ljunggren, G Piontek, R Kiessling
Nature 319 (6055), 675-678, 1986
26461986
„Natural” killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype
R Kiessling, E Klein, H Wigzell
European journal of immunology 5 (2), 112-117, 1975
23751975
„Natural” killer cells in the mouse. II. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Characteristics of the killer cell
R Kiessling, E Klein, H Pross, H Wigzell
European journal of immunology 5 (2), 117-121, 1975
14311975
The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations
B Agerberth, J Charo, J Werr, B Olsson, F Idali, L Lindbom, R Kiessling, ...
Blood, The Journal of the American Society of Hematology 96 (9), 3086-3093, 2000
9312000
Heat-shock proteins as activators of the innate immune system
RPA Wallin, A Lundqvist, SH Moré, A von Bonin, R Kiessling, ...
Trends in immunology 23 (3), 130-135, 2002
7222002
Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts
R Kiessling, PS Hochman, O Haller, GM Shearer, H Wigzell, G Cudkowicz
European journal of immunology 7 (9), 655-663, 1977
5701977
Regulatory T cells in cancer
D Mougiakakos, A Choudhury, A Lladser, R Kiessling, CC Johansson
Advances in cancer research 107, 57-117, 2010
5372010
Classification of current anticancer immunotherapies
L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ...
Oncotarget 5 (24), 12472, 2014
4562014
An analysis of the murine NK cell as to structure, function and biological relevance
R Kiessling, H Wigzell
Immunological reviews 44 (1), 165-208, 1979
4541979
Immature immunosuppressive CD14+ HLA-DR−/low cells in melanoma patients are Stat3hi and overexpress CD80, CD83, and DC-sign
I Poschke, D Mougiakakos, J Hansson, GV Masucci, R Kiessling
Cancer research 70 (11), 4335-4345, 2010
4512010
Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
H Nakagomi, M Petersson, I Magnusson, C Juhlin, M Matsuda, ...
Cancer research 53 (23), 5610-5612, 1993
4241993
Hydrogen peroxide secreted by tumor‐derived macrophages down‐modulates signal‐transducing zeta molecules and inhibits tumor‐specific T cell‐and natural killer cell‐mediated …
K Kono, F Salazar‐Onfray, M Petersson, J Hansson, G Masucci, ...
European journal of immunology 26 (6), 1308-1313, 1996
4181996
Interleukin 10 pretreatment protects target cells from tumor-and allo-specific cytotoxic T cells and downregulates HLA class I expression.
M Matsuda, F Salazar, M Petersson, G Masucci, J Hansson, P Pisa, ...
The Journal of experimental medicine 180 (6), 2371-2376, 1994
4061994
Role of non-conventional natural killer cells in resistance against syngeneic tumour cells in vivo
O Haller, M Hansson, R Kiessling, H Wigzell
Nature 270 (5638), 609-611, 1977
3641977
Tumor-induced immune dysfunction
R Kiessling, K Wasserman, S Horiguchi, K Kono, J Sjöberg, P Pisa, ...
Cancer immunology, immunotherapy 48 (7), 353-362, 1999
3241999
Circulating heat shock protein 60 is associated with early cardiovascular disease
AG Pockley, R Wu, C Lemne, R Kiessling, U de Faire, J Frostegård
Hypertension 36 (2), 303-307, 2000
3152000
Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies.
P Pisa, E Halapi, EK Pisa, E Gerdin, C Hising, A Bucht, B Gerdin, ...
Proceedings of the National Academy of Sciences 89 (16), 7708-7712, 1992
3081992
Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non‐immunized semi‐syngeneic mice against a mouse lymphoma line
R Kiessling, G Petranyi, G Klein, H Wigzell
International journal of cancer 15 (6), 933-940, 1975
2851975
Target-effector interaction in the natural killer (NK) cell system: II. The isolation of NK cells and studies on the mechanism of killing
JC Roder, R Kiessling, P Biberfeld, B Andersson
The Journal of Immunology 121 (6), 2509-2517, 1978
2761978
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells
M Carlsten, NK Björkström, H Norell, Y Bryceson, T van Hall, ...
Cancer research 67 (3), 1317-1325, 2007
2682007
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20